Nanotechnology in triple-negative breast cancer: A review of nanocarrier systems for enhanced efficacy and reduced toxicity

Qazi Saifullah; Sajid Mondal; Amartya Nandi; Madhuri Yeduvaka; Suvadra Das; Partha Roy

doi:10.1039/d5na00907c

January 1, 2026Nanoscale AdvancesOpen Access

Nanotechnology in triple-negative breast cancer: A review of nanocarrier systems for enhanced efficacy and reduced toxicity

View Full Paper

Ask AI

Bookmark

Share

Key Points

The central aim is to review the role of nanocarrier systems in improving treatment efficacy and reducing toxicity in triple-negative breast cancer.
Conducted a comprehensive review of various nanocarrier systems used in TNBC treatments.
Evaluated the effectiveness of different formulations in delivering chemotherapy and targeted therapies.
Analyzed existing literature to identify trends and gaps in current nanotechnology applications for TNBC.
Nanocarrier systems enhance drug delivery and increase therapeutic efficacy against TNBC.
Reduction in toxicity was observed in multiple studies, improving patient safety.
Diverse approaches in nanocarrier design showed promise in overcoming treatment challenges specific to TNBC.

Implication

A review examines how nanocarrier systems improve treatment effectiveness in triple-negative breast cancer, suggesting new therapeutic pathways.

Abstract

The aggressive and extremely diverse subtype of breast cancer known as triple-negative breast cancer (TNBC) lacks HER2, progesterone, and oestrogen receptors, which limits treatment options and increases the risk of...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Saifullah et al. (2026) studied this question.

synapsesocial.com/papers/69e9baa885696592c86ecaf4 https://doi.org/10.1039/d5na00907c

View Full Paper

Ask AI

Bookmark

Share

Nanotechnology in triple-negative breast cancer: A review of nanocarrier systems for enhanced efficacy and reduced toxicity

Key Points

Implication

Abstract

Discussion

Cite This Study

Nanotechnology in triple-negative breast cancer: A review of nanocarrier systems for enhanced efficacy and reduced toxicity

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading